|
Nishino Takayoshi
Department School of Medicine(Yachiyo Medical Center), School of Medicine Position Professor |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Clinical practice guidelines for IgG4-related sclerosing cholangitis. |
| Journal | Formal name：Journal of hepato-biliary-pancreatic sciences Abbreviation：J Hepatobiliary Pancreat Sci ISSN code：18686982/18686974 |
| Volume, Issue, Page | 26(1),pp.9-42 |
| Author and coauthor | Kamisawa Terumi, Nakazawa Takahiro, Tazuma Susumu, Zen Yoh, Tanaka Atsushi, Ohara Hirotaka, Muraki Takashi, Inui Kazuo, Inoue Dai, Nishino Takayoshi, Naitoh Itaru, Itoi Takao, Notohara Kenji, Kanno Atsushi, Kubota Kensuke, Hirano Kenji, Isayama Hiroyuki, Shimizu Kyoko, Tsuyuguchi Toshio, Shimosegawa Tooru, Kawa Shigeyuki, Chiba Tsutomu, Okazaki Kazuichi, Takikawa Hajime, Kimura Wataru, Unno Michiaki, Yoshida Masahiro |
| Publication date | 2019/01 |
| Summary | IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria of IgG4-SC were established in 2012, differential diagnosis from primary sclerosing cholangitis and cholangiocarcinoma is sometimes difficult. Furthermore, no practical guidelines for IgG4-SC are available. Because the evidence level of most articles retrieved through searching the PubMed, Cochrane Library, and Igaku Chuo Zasshi databases was below C based on the systematic review evaluation system of clinical practice guidelines MINDS 2014, we developed consensus guidelines using the modified Delphi approach. Three committees (a guideline creating committee, an expert panelist committee for rating statements according to the modified Delphi method, and an evaluating committee) were organized. Eighteen clinical questions (CQs) with clinical statements were developed regarding diagnosis (14 CQs) and treatment (4 CQs). Recommendation levels for clinical statements were set using the modified Delphi approach. The guidelines explain methods for accurate diagnosis, and safe and appropriate treatment of IgG4-SC. |
| DOI | 10.1002/jhbp.596 |
| PMID | 30575336 |